Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Reexamination Certificate
2011-08-02
2011-08-02
Pak, Yong (Department: 1652)
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
C435S004000, C435S006120, C435S069100, C435S071100, C435S320100, C435S189000, C435S183000, C435S195000, C536S023200, C530S350000
Reexamination Certificate
active
07989193
ABSTRACT:
The present invention relates a host cell comprising an expression vector comprising a nucleic acid molecule encoding a protein requiring gamma-carboxylation and associated expression control sequences and a nucleic acid molecule encoding a vitamin K epoxido reductase and associated expression control sequences and a nucleic acid molecule encoding a γ-glutamyl carboxylase and associated control sequences. The invention further relates to a method of producing a protein requiring gamma-carboxylation in high yields.
REFERENCES:
patent: 4404187 (1983-09-01), Schwinn et al.
patent: 4599308 (1986-07-01), Hamer et al.
patent: 4784950 (1988-11-01), Hagen et al.
patent: 5118614 (1992-06-01), Rybak et al.
patent: 5122458 (1992-06-01), Post et al.
patent: 5648254 (1997-07-01), Mulvihill et al.
patent: 5866122 (1999-02-01), Turecek et al.
patent: 5958893 (1999-09-01), Welsh et al.
patent: 5965789 (1999-10-01), Lubon et al.
patent: 6039945 (2000-03-01), Turecek et al.
patent: 6165974 (2000-12-01), Turecek et al.
patent: 6224862 (2001-05-01), Turecek et al.
patent: 6224864 (2001-05-01), Argoudelis et al.
patent: 6342372 (2002-01-01), Dubensky et al.
patent: 6413737 (2002-07-01), Osen et al.
patent: 7482141 (2009-01-01), Stafford et al.
patent: 7842477 (2010-11-01), Fenge et al.
patent: 2002/0106381 (2002-08-01), High
patent: 2004/0197858 (2004-10-01), Yonemura et al.
patent: 2005/0164367 (2005-07-01), Fenge et al.
patent: 2008/0045453 (2008-02-01), Drohan et al.
patent: 2008/0312127 (2008-12-01), Lovgren
patent: 2009/0047273 (2009-02-01), Harrysson et al.
patent: 0052827 (1982-06-01), None
patent: 0607392 (1994-07-01), None
patent: 0700682 (1996-03-01), None
patent: 1 407 780 (2004-04-01), None
patent: 1405910 (2004-04-01), None
patent: 1405912 (2004-04-01), None
patent: 1676911 (2006-07-01), None
patent: WO 88/03926 (1988-06-01), None
patent: WO 89/12685 (1989-12-01), None
patent: WO 92/01795 (1992-02-01), None
patent: WO 92/19636 (1992-11-01), None
patent: WO 96/34966 (1996-11-01), None
patent: WO 96/34966 (1996-11-01), None
patent: WO 99/033983 (1999-07-01), None
patent: WO 01/04146 (2001-01-01), None
patent: WO 01/07068 (2001-02-01), None
patent: WO 02/29045 (2002-04-01), None
patent: WO 02/29045 (2002-04-01), None
patent: WO 02/29083 (2002-04-01), None
patent: WO 02/29083 (2002-04-01), None
patent: WO 2005/030039 (2005-04-01), None
patent: WO 2005/038019 (2005-04-01), None
patent: WO 2005/040367 (2005-05-01), None
patent: WO 2006/067116 (2006-06-01), None
patent: WO 2006/110083 (2006-10-01), None
patent: WO 2007/065173 (2007-06-01), None
Gamma Glutamyl Carboxylase. UniPro Database. [online], [retireved on Jan. 14, 2010] Retrieved from the UniPro Database using Internet <URL: http://www.uniprot.org/uniprot/?query=gamma+glutamyl+carboxylase&sort=score>.
Bandyopadhyay et al., “γ-Glutamyl carboxylation: an extracellular posttranslational modification that antedates the divergence of molluscs, anthropods, and chordates,”PNAS99(3):1264-1269 (2002).
Begley et al., “A conserved motif within the vitamin K-dependent carboxylase gene is widely distributed across animal phyla,”J. Biol. Chem. 275(46):36245-36249 (2000).
Cote et al., “Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A),”J. Biol. Chem. 269(15):11374-11380 (1994).
Czerwiec et al., “Expression and characterization of recombinant vitamin K-dependent γ-glutamyl carboxylase from an invertebrate,Conus textile,” Eur. J. Biochem. 269:6162-6172 (2002).
Fischer et al., “Purification of recombinant human coagulation factors II and IX and protein S expressed in recombinant Vaccinia virus-infected Vero cells,”Journal of Biotechnology38:129-136 (1995).
Hallgren et al., “Carboxylase overexpression effects full carboxylation but poor release and secretion of a factor IX: implications for the release of vitamin K-dependent proteins,”Biochemistry41:15045-15055 (2002).
Harvey et al., “Mutagenesis of the γ-carboxyglutamic acid domain of human factor VII to generate maximum enhancement of the membrane contact site,”J. Biol. Chem. 278(10):8363-8369 (2003).
Herlitschka et al., “Overexpression of human prothrombin in permanent cell lines using a dominant selection/amplification fusion marker,”Protein Expression and Purification8:358-364 (1996).
Himmelspach et al., “A Fully Recombinant Partial Prothrombin Complex Effectively Bypasses fVII in Vitro and in Vivo,”Thromb Haemost88:1003-1011 (2002).
Jorgensen et al., “Expression of completely γ-carboxylated recombinant human prothrombin,”J. Biol. Chem. 262(14):6729-6734 (1987).
Li et al., “Identification of the gene for vitamin K epoxide reductase”,Nature427:541-544 (2004).
Malhotra et al., “The kinetics of activation of normal and γ-carboxyglutamic acid-deficient prothrombins,”J. Biol. Chem. 260:279-287 (1985).
Rehemtulla et al., “In vitro and in vivo functional characterization of bovine vitamin K-dependent γ-carboxylase expressed in Chinese hamster ovary cells,”Proc. Natl. Acad. Sci. 90:4611-4615 (1993).
Roddie at al., “Haemostasis and thrombosis: Recombinant coagulation factors,”Blood Reviews11:169-177 (1997).
Russo et al., “Biologically active recombinant prothrombin and antithrombin III expressed in a human hepatoma/vaccinia virus system,”Biotechnology and Applied Biochemistry14:222-223 (1991).
Russo et al., “Stable expression and purification of a secreted human recombinant prethrombin-2 and its activation to thrombin,”Protein Expression and Purification10:214-225 (1997).
Scharrer et al., “Products used to treat hemophilia: evolution of treatment for hemophilia A and B,” in: Lee et al., eds.,Textbook of Hemophilia(New York, Blackwell, 2005), Ch. 23, pp. v-x and 131-135.
Stanley et al., “The propeptides of the vitamin K-dependent proteins possess different affinities for the vitamin K-dependent carboxylase,”J. Biol. Chem. 274(24):16940-16944 (1999).
Sun et al., “Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X,”Blood106(12):3811-3815 (2005).
Vo et al., “Undercarboxylation of recombinant prothrombin revealed by analysis of γ-carboxyglutamic acid using capillary electrophoresis and laser-induced fluorescence,”Febs Letters445:256-260 (1999).
Wajih et al., “Engineering of a Recombinant Vitamin K-dependent γ-Carboxylation System with Enhanced γ-Carboxyglutamic Acid Forming Capacity,”J. Biol. Chem. 280:10540-10547 (2005).
Wajih et al., “Increased Production of Functional Recombinant Human Clotting Factor IX by Baby Hamster Kidney Cells Engineered to Overexpress VKORC1, the Vitamin K 2,3-Expoxide-reducing Enzyme of the Vitamin K Cycle,”J. Biol. Chem. 280:31603-31607 (2005).
Walker at al., “On a potential global role for vitamin K-dependent γ-carboxylation in animal systems,”J. Biol. Chem. 276(11):7769-7774 (2001).
Wu et al., “Cloning and expression of the cDNA for human γ-glutamyl carboxylase,”Science254:1634-1636 (1991).
Wu et al., “N-Glycosylation contributes to the intracellular stability of prothrombin precursors in the endoplasmic reticulum,”Thrombosis Research96:91-98 (1999).
Zhang et al., “Relative Promoter Strengths in Four Human Prostate Cancer Cell Lines Evaluated by Particle Bombardment-Mediated Gene Transfer,”The Prostate, 51:286-292 (2002).
USPTO Restriction Requirement in U.S. Appl. No. 12/167,614, mailed Apr. 6, 2009, 8 pages.
Fish & Richardson P.C., Amendment in Reply to Restriction Requirement dated Apr. 6, 2009, in U.S. Appl. No. 12/167,614, filed Aug. 4, 2009, 9 pages.
USPTO Restriction Requirement in U.S. Appl. No. 10/964,888, mailed Aug. 9, 2006, 10 pages.
Fish & Richardson P.C., Amendment in Reply to Restriction Requi
Fish & Richardson P.C.
MedImmune Limited
Pak Yong
LandOfFree
Compositions and methods for producing gamma-carboxylated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for producing gamma-carboxylated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for producing gamma-carboxylated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2659178